Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Alnorin reported in phase I

April 19, 1996

Estrasine presented at NCI-EORTC

April 19, 1996

CB-30865 selected for further study

April 19, 1996

Ciba-Geigy selects CGP-61755 for development

April 19, 1996

NT-3 shows potential in diabetic neuropathy

April 12, 1996

Selective protein kinase C beta antagonist discovered by Lilly

April 12, 1996

New thiazolidinedione, MCC-555, reported by Mitsubishi Chemical

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

YM-087 in phase I for CHF

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...